ArticleBiotechnology reports (Amsterdam, Netherlands)2026
AAV-mediated delivery of CRISPR/Cas9 targeting conserved overlapping ORFs efficiently suppresses HBV replication in hepatocyte models.
Pattida Kongsomboonchoke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.